Is Ketamine Legal in Wisconsin? (2026)

Instrument

Controlled substances board; federal designation, rescheduling or deletion

Source

https://docs.legis.wisconsin.gov/statutes/statutes/961/II/11

Retrieved

2026-11-06

Fingerprint

d0f0bd0dbefadfdb

If a substance is designated, rescheduled or deleted as a controlled substance under federal law and notice thereof is given to the controlled substances board, the board by affirmative action shall similarly treat the substance under this chapter after the expiration of 30 days from the date of publication in the federal register of a final order designating the substance as a controlled substance or rescheduling or deleting the substance or from the date of issuance of an order of temporary scheduling under
21 USC 811
 (h), unless within that 30-day period, the board or an interested party objects to the treatment of the substance.  If no objection is made, the board shall promulgate, without making the determinations or findings required by subs.
(1)
,
(1m)
,
(1r)
 and
(2)
 or s.
961.13
,
961.15
,
961.17
,
961.19
 or
961.21
, a final rule, for which notice of proposed rule making is omitted, designating, rescheduling, temporarily scheduling or deleting the substance.  If an objection is made the board shall publish notice of receipt of the objection and the reasons for objection and afford all interested parties an opportunity to be heard.  At the conclusion of the hearing, the board shall make a determination with respect to the treatment of the substance as provided in subs.
(1)
,
(1m)
,
(1r)
 and
(2)
 and shall publish its decision, which shall be final unless altered by statute.  Upon publication of an objection to the treatment by the board, action by the board under this chapter is stayed until the board promulgates a rule under sub.
(2)
.

Instrument

Schedule I, hallucinogenic substances

Source

https://docs.legis.wisconsin.gov/statutes/statutes/961/II/14/4

Retrieved

2026-11-06

Fingerprint

5e8264ce9210e132

961.14(4)
(4)
 
Hallucinogenic substances.
  Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:
961.14(4)(a)
(a)
  3,4-methylenedioxyamphetamine, commonly known as "MDA";
961.14(4)(ag)
(ag)
  3,4-methylenedioxyethylamphetamine, commonly known as “MDE”;
961.14(4)(am)
(am)
  3,4-methylenedioxymethamphetamine, commonly known as “MDMA”;
961.14(4)(ar)
(ar)
  N-hydroxy-3,4-methylenedioxyamphetamine;
961.14(4)(b)
(b)
  5-methoxy-3,4-methylenedioxyamphetamine;
961.14(4)(bm)
(bm)
  4-ethyl-2,5-dimethoxyamphetamine, commonly known as “DOET”;
961.14(4)(c)
(c)
  3,4,5-trimethoxyamphetamine;
961.14(4)(cm)
(cm)
  Alpha-ethyltryptamine;
961.14(4)(d)
(d)
  Bufotenine;
961.14(4)(e)
(e)
  Diethyltryptamine;
961.14(4)(f)
(f)
  Dimethyltryptamine;
961.14(4)(g)
(g)
  4-methyl-2,5-dimethoxyamphetamine, commonly known as “STP”;
961.14(4)(h)
(h)
  Ibogaine;
961.14(4)(j)
(j)
  Lysergic acid diethylamide, commonly known as "LSD";
961.14(4)(jm)
(jm)
  1-propionyl-lysergic acid diethylamide, commonly known as 1P-LSD;
961.14(4)(m)
(m)
  Mescaline, in any form, including mescaline contained in peyote, obtained from peyote or chemically synthesized;
961.14(4)(mn)
(mn)
  Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo(b, d)pyran);
961.14(4)(n)
(n)
  Phencyclidine, commonly known as "PCP";
961.14(4)(p)
(p)
  N-ethyl-3-piperidyl benzilate;
961.14(4)(q)
(q)
  N-methyl-3-piperidyl benzilate;
961.14(4)(r)
(r)
  Psilocybin;
961.14(4)(s)
(s)
  Psilocin;

Instrument

Schedule I; hallucinogenic substances

Source

https://docs.legis.wisconsin.gov/statutes/statutes/961/II/14/4

Retrieved

2026-10-31

Fingerprint

a0d031ce6ede0dc0

(4)
Hallucinogenic substances.
  Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:
(a)
  3,4-methylenedioxyamphetamine, commonly known as "MDA";
(ag)
  3,4-methylenedioxyethylamphetamine, commonly known as “MDE”;
(am)
  3,4-methylenedioxymethamphetamine, commonly known as “MDMA”;
(ar)
  N-hydroxy-3,4-methylenedioxyamphetamine;
(b)
  5-methoxy-3,4-methylenedioxyamphetamine;
(bm)
  4-ethyl-2,5-dimethoxyamphetamine, commonly known as “DOET”;
(c)
  3,4,5-trimethoxyamphetamine;
(cm)
  Alpha-ethyltryptamine;
(d)
  Bufotenine;
(e)
  Diethyltryptamine;
(f)
  Dimethyltryptamine;
(g)
  4-methyl-2,5-dimethoxyamphetamine, commonly known as “STP”;
(h)
  Ibogaine;
(j)
  Lysergic acid diethylamide, commonly known as "LSD";
(jm)
  1-propionyl-lysergic acid diethylamide, commonly known as 1P-LSD;
(m)
  Mescaline, in any form, including mescaline contained in peyote, obtained from peyote or chemically synthesized;
(mn)
  Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo(b, d)pyran);
(n)
  Phencyclidine, commonly known as "PCP";
(p)
  N-ethyl-3-piperidyl benzilate;
(q)
  N-methyl-3-piperidyl benzilate;
(r)
  Psilocybin;
(s)
  Psilocin;
(sm)
  Salvinorin A;

Instrument

Schedule III; other substances

Source

https://docs.legis.wisconsin.gov/statutes/statutes/961/II/18

Retrieved

2026-10-31

Fingerprint

a88387b0ec4f90aa

Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule III:
(2m)
 
Stimulants.
  Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
(a)
  Benzphetamine;
(b)
  Chlorphentermine;
(c)
  Clortermine;
(e)
  Phendimetrazine.
(3)
 
Depressants.
  Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
(a)
  Any substance which contains a derivative of barbituric acid;
(b)
  Chlorhexadol;
(bm)
  Embutramide;
(d)
  Lysergic acid;
(e)
  Lysergic acid amide;
(f)
  Methyprylon;
(fm)
  Perampanel;
(h)
  Sulfondiethylmethane;
(j)
  Sulfonethylmethane;
(k)
  Sulfonmethane;
(km)
  Tiletamine and Zolazepam in combination;
(m)
  Any compound, mixture, or preparation containing any of the following drugs and one or more other active medicinal ingredients not included in any schedule:
1.
  Amobarbital.
2.
  Secobarbital.
3.
  Pentobarbital.
(n)
  Any of the following drugs in suppository dosage form approved by the federal food and drug administration for marketing only as a suppository:
1.
  Amobarbital.
2.
  Secobarbital.
3.
  Pentobarbital.
(o)
  Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the federal food, drug and cosmetic act:
1.
  Gamma-hydroxybutyric acid.
(4)
 
Other substances.
  Any material, compound, mixture or preparation which contains any quantity of any of the following substances, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
(ak)
  Ketamine.
(an)
  Nalorphine.

Instrument

Schedule I, hallucinogenic substances

Source

https://docs.legis.wisconsin.gov/statutes/statutes/961.pdf

Retrieved

2026-10-28

Fingerprint

728f0e845cae4adf

(4)  HALLUCINOGENIC  SUBSTANCES.    Any  material,  com-
pound, mixture or preparation which contains any quantity of any
of the following hallucinogenic substances, including any of their
salts, isomers, esters, ethers, and salts of isomers, esters, or ethers
that are theoretically possible within the specific chemical desig-
nation, in any form contained in a plant, obtained from a plant, or
chemically synthesized:

7h.

  N-desethyl  protonitazene  (N-ethyl-2-(5-nitro-2-(4-

(a)    3,4-methylenedioxyamphetamine,  commonly  known  as

propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine).

7k.  N,N-dimethylamino etonitazene (2-(2-(4-ethoxybenzyl)-

"MDA";
(ag)

  3,4-methylenedioxyethylamphetamine,  commonly

5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine).

known as “MDE”;

7m.  N-piperidinyl etonitazene also known as etonitazepipne

(am)

  3,4-methylenedioxymethamphetamine,  commonly

(2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-
benzimidazole).

8.    N-pyrrolidino  etonitazene  also  known  as  etonitazepyne

(2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
benzimidazole).

8b.  N-pyrrolidino isotonitazene (2-(4-isopropoxybenzyl)-5-

nitro-1-(2-(pyrrolindin-1-yl)ethyl)-1H-benzimidazole).

8e.    N-pyrrolidino  metonitazene  also  known  as  metoni-
(2-(4-methyoxbenzyl)-5-nitro-1-(2-(pyrrolidin-1-

tazepyne
yl)ethyl)-1H-benzimidazole).

8m.    N-pyrrolidino  protonitazene  also  known  as  protoni-
(5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-

tazepyne
yl)ethyl)-1H-benzimidazole).

9.  Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxyben-

zyl)-1H-benzimidazol-1- yl)ethan-1-amine).

(xr)  Tilidine;
(y)  Trimeperidine.
(z)  U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-

N-methylbenzamide).

(zm)

Zipeprol

(1-methoxy-3-[4-(2-methoxy-2-

phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol).

(3)  SUBSTANCES DERIVED FROM OPIUM.  Any material, com-
pound, mixture or preparation which contains any quantity of any
of the following substances derived from opium, including any of
their salts, isomers and salts of isomers that are theoretically pos-
sible within the specific chemical designation:

(a)  Acetorphine;
(b)  Acetyldihydrocodeine;
(c)  Benzylmorphine;

known as “MDMA”;

(ar)  N-hydroxy-3,4-methylenedioxyamphetamine;
(b)  5-methoxy-3,4-methylenedioxyamphetamine;
(bm)  4-ethyl-2,5-dimethoxyamphetamine, commonly known

as “DOET”;

(c)  3,4,5-trimethoxyamphetamine;
(cm)  Alpha-ethyltryptamine;
(d)  Bufotenine;
(e)  Diethyltryptamine;
(f)  Dimethyltryptamine;
(g)  4-methyl-2,5-dimethoxyamphetamine, commonly known

as “STP”;

(h)  Ibogaine;
(j)  Lysergic acid diethylamide, commonly known as "LSD";
(jm)    1-propionyl-lysergic  acid  diethylamide,  commonly

known as 1P-LSD;

(m)  Mescaline, in any form, including mescaline contained in

peyote, obtained from peyote or chemically synthesized;

(mn)  Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6,

6, 9-trimethyl-6H-dibenzo(b, d)pyran);

(n)  Phencyclidine, commonly known as "PCP";
(p)  N-ethyl-3-piperidyl benzilate;
(q)  N-methyl-3-piperidyl benzilate;
(r)  Psilocybin;
(s)  Psilocin;
(sm)  Salvinorin A;
(t)    Tetrahydrocannabinols,  commonly  known  as  “THC”,  in
any  form  including  tetrahydrocannabinols  contained  in  mari-

2023-24 Wisconsin Statutes updated through 2025 Wis. Act 247 and through all Supreme Court Orders and Controlled Sub-
stances Board Orders filed before and in effect on October 1, 2026.  Published and certified under s. 35.18.  Changes effective af-
ter October 1, 2026, are designated by NOTES. (Published 10-1-26)

Updated 2023-24 Wis. Stats.  Published and certified under s. 35.18.  October 1, 2026.

 961.14

UNIFORM CONTROLLED SUBSTANCES ACT

Updated 23-24 Wis. Stats.

  8

juana,  obtained  from  marijuana,  or  chemically  synthesized,  ex-
cept  that  tetrahydrocannabinols  do  not  include  any  of  the
following:

1.  Tetrahydrocannabinols contained in a cannabidiol product
that is dispensed as provided in s. 961.38 (1n) (a) or that is pos-
sessed as provided in s. 961.32 (2m) (b).

2.  Tetrahydrocannabinols contained in fiber produced from
the stalks, oil or cake made from the seeds of a Cannabis plant,
any  other  compound,  manufacture,  salt,  derivative,  mixture  or
preparation of the mature stalks (except the resin extracted there-
from), fiber, oil or cake or the sterilized seed of a Cannabis plant
which is incapable of germination.

3.  Tetrahydrocannabinols contained in hemp, as defined in s.

94.55 (1).

4.    A  drug  product  in  finished  dosage  formulation  that  has
been approved by the United States food and drug administration
that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-
2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol)
from
cannabis  and  no  more  than  0.1  percent  (w/w)  residual
tetrahydrocannabinols.

derived

(tb)  Synthetic cannabinoids, including:
1.    Any  compound  structurally  derived  from  3-(1-naph-
thoyl)indole  or  1H-indol-3-yl-(1-naphthyl)methane  by  substitu-
tion at the nitrogen atom of the indole ring by alkyl, haloalkyl,
cyanoalkyl,  alkenyl,  cycloalkylmethyl,  cycloalkylethyl,  1-(N-
methyl-2-piperidinyl)methyl,
1-(N-
1-(N-methyl-3-mor-
methyl-2-pyrrolidinyl)methyl,
pholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether
or not further substituted in the indole ring to any extent, whether
or not substituted in the naphthyl ring to any extent.  Substances
specified under this subdivision include:

2-(4-morpholinyl)ethyl,

a.

  1-pentyl-2-methyl-3-(1-naphthoyl)indole,  commonly

known as JWH-007;

b.

  1-propyl-2-methyl-3-(1-naphthoyl)indole,  commonly

known as JWH-015;

c.    1-pentyl-3-(1-naphthoyl)indole,  commonly  known  as

JWH-018 or AM-678;

d.    1-hexyl-3-(1-naphthoyl)indole,  commonly  known  as

JWH-019;

e.    1-butyl-3-(1-naphthoyl)indole,  commonly  known  as

JWH-073;

f.    1-pentyl-3-(4-methoxy-1-naphthoyl)indole,  commonly

known as JWH-081;

g.

  1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole,

commonly known as JWH-098;

h.

  1-pentyl-3-(4-methyl-1-naphthoyl)indole,  commonly

known as JWH-122;

i.    1-pentyl-3-(7-methoxy-1-naphthoyl)indole,  commonly

known as JWH-164;

j.  1-[2-(4-(morpholinyl)ethyl)]-3-(1-naphthoyl)indole, com-

monly known as JWH-200;

q.

  1-(5-chloropentyl)-3-(1-naphthoyl)indole,  commonly

known as AM-2201 (5-chloropentyl);

r.

  1-(5-bromopentyl)-3-(1-naphthoyl)indole,  commonly

known as AM-2201 (5-bromopentyl);

s.

  1-(4-cyanobutyl)-3-(1-naphthoyl)indole,  commonly

known as AM-2232;

t.

(R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-

methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-
methanone, commonly known as WIN 55,212-2;

2.    Any  compound  structurally  derived  from  3-(1-naph-
thoyl)pyrrole by substitution at the nitrogen atom of the pyrrole
ring  by  alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cycloalkylmethyl,
cycloalkylethyl,  1-(N-methyl-2-piperidinyl)methyl,  2-(4-mor-
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-
3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not further substituted in the pyrrole ring to any ex-
tent, whether or not substituted in the naphthyl ring to any extent.
Substances specified under this subdivision include:

a.  1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole, com-

monly known as JWH-307;

b.

  1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole,

commonly known as JWH-370;

c.    1-pentyl-3-(1-naphthoyl)pyrrole,  commonly  known  as

JWH-030;
d.

  1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole,  commonly

known as JWH-147;

1-(N-methyl-2-piperidinyl)methyl,

3.    Any  compound  structurally  derived  from  3-naphthyl-
methylindene by substitution at the 1-position of the indene ring
by  alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cycloalkylmethyl,  cy-
cloalkylethyl,
2-(4-mor-
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-
3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not further substituted in the indene ring to any extent,
whether  or  not  substituted  in  the  naphthyl  ring  to  any  extent.
Substances specified under this subdivision include 1-pentyl-3-
(1-naphthylmethyl)indene, commonly known as JWH-176;

4.    Any  compound  structurally  derived  from  3-pheny-
lacetylindole  by  substitution  at  the  nitrogen  atom  of  the  indole
ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl,  1-(N-methyl-2-piperidinyl)methyl,  2-(4-mor-
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-
3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the phenyl ring to any extent.  Sub-
stances specified under this subdivision include:

a.    1-pentyl-3-(4-methoxyphenylacetyl)indole,  commonly

known as JWH-201;

b.    1-pentyl-3-(3-methoxyphenylacetyl)indole,  commonly

known as JWH-302;

c.    1-pentyl-3-(2-methoxyphenylacetyl)indole,  commonly

known as JWH-250;

d.

  1-pentyl-3-(2-chlorophenylacetyl)indole,  commonly

k.

  1-pentyl-3-(4-ethyl-1-naphthoyl)indole,

commonly

known as JWH-203;

known as JWH-210;

e.  1-pentyl-3-(3-chlorophenylacetyl)indole, or 3-chloro iso-

L.

  1-pentyl-3-(4-chloro-1-naphthoyl)indole,  commonly

mer of JWH-203;

known as JWH-398;

f.  1-pentyl-3-(4-chlorophenylacetyl)indole, or 4-chloro iso-

m.

  1-pentyl-3-(4-fluoro-1-naphthoyl)indole,  commonly

mer of JWH-203;

known as JWH-412;

g.

  1-pentyl-3-(2-methylphenylacetyl)indole,  commonly

n.    1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-naphthoyl)in-

known as JWH-251;

dole, commonly known as AM-1220;

h.    1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole,

o.

  1-(5-fluoropentyl)-3-(1-naphthoyl)indole,  commonly

commonly known as RCS-8;

known as AM-2201;

p.  1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole, com-

monly known as MAM-2201;

i.

methoxyphenylacetyl)indole,
cannabipiperidiethanone;

1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-
as

commonly

known

2023-24 Wisconsin Statutes updated through 2025 Wis. Act 247 and through all Supreme Court Orders and Controlled Sub-
stances Board Orders filed before and in effect on October 1, 2026.  Published and certified under s. 35.18.  Changes effective af-
ter October 1, 2026, are designated by NOTES. (Published 10-1-26)

Updated 2023-24 Wis. Stats.  Published and certified under s. 35.18.  October 1, 2026.

9  Updated 23-24 Wis. Stats.

UNIFORM CONTROLLED SUBSTANCES ACT

961.14

5.  Any compound structurally derived from 2-(3-hydroxycy-
clohexyl)phenol by substitution at the 5-position of the phenolic
ring  by  alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cycloalkylmethyl,
cycloalkylethyl,  1-(N-methyl-2-piperidinyl)methyl,  2-(4-mor-
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-
3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not substituted in the cyclohexyl ring to any extent.
Substances specified under this subdivision include:

a.

  2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-

yl)phenol, commonly known as CP 47,497;

b.

  2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-
yl)phenol,  commonly  known  as  CP  47,497  C8  homologue,  or
cannabicyclohexanol;

1-(N-methyl-2-piperidinyl)methyl,

6.  Any compound structurally derived from 3-(benzoyl)in-
dole  by  substitution  at  the  nitrogen  atom  of  the  indole  ring  by
alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cycloalkylmethyl,  cy-
2-(4-mor-
cloalkylethyl,
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-
3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not further substituted in the indole ring to any extent
and whether or not substituted in the phenyl ring to any extent.
Substances specified under this subdivision include:

whether or not substituted in the cyclopropyl ring to any extent.
Substances specified under this subdivision include:

a.  1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole, com-

monly known as UR-144;

b.  1-(5-chloropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)in-

dole, commonly known as 5Cl-UR-144;

c.  1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)in-

dole, commonly known as XLR-11;

d.    1-[2-(4-morpholinyl)ethyl]-3-(2,2,3,3-tetramethylcyclo-

propoyl)indole, commonly known as A-796,260;

e.    1-[(tetrahydropyran-4-yl)methyl]-3-(2,2,3,3-tetramethyl-

cyclopropoyl)indole, commonly known as A-834,735;

9.    Any  compound  structurally  derived  from  N-adamantyl-
1H-indole-3-carboxamide by substitution at the nitrogen atom of
the  indole  ring  with  alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cy-
1-(N-methyl-2-
cloalkylmethyl,
cycloalkylethyl,
1-(N-methyl-2-
piperidinyl)methyl,
pyrrolidinyl)methyl,
or
(tetrahydropyran-4-yl)methyl group, whether or not further sub-
stituted in the indole ring to any extent, whether or not substituted
in the adamantyl ring to any extent.  Substances specified under
this subdivision include:

2-(4-morpholinyl)ethyl,
1-(N-methyl-3-morpholinyl)methyl,

a.    1-pentyl-3-(2-iodobenzoyl)indole,  commonly  known  as

a.

  N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide,

AM-679;

commonly known as 2NE1;

b.    1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole,  commonly

b.  N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carbox-

known as AM-694;

c.  1-pentyl-3-(4-methoxybenzoyl)indole, commonly known

as RCS-4;

d.    1-butyl-3-(4-methoxybenzoyl)indole,  commonly  known

as RCS-4-C4 homologue;

e.  1-pentyl-3-(2-methoxybenzoyl)indole, commonly known

as RCS-4 2-methoxy isomer;

f.  1-butyl-3-(2-methoxybenzoyl)indole, a C4 homologue, 2-

methoxy isomer of RCS-4;

g.    1-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxyben-

zoyl)indole, commonly known as pravadoline, or WIN 48,098;

h.    1-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxyben-
zoyl)-6-iodo-indole, commonly known as 6-iodopravadoline, or
AM-630;
i.

  1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodo-5-ni-

trobenzoyl)indole, commonly known as AM-1241;

j.

1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodoben-

zoyl)indole, commonly known as AM-2233;

1-(N-methyl-2-piperidinyl)methyl,

7.  Any compound structurally derived from 3-adamantoylin-
dole by substitution at the nitrogen atom of the indole ring with
alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cycloalkylmethyl,  cy-
cloalkylethyl,
2-(4-mor-
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-
3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not further substituted in the indole ring to any extent,
whether  or  not  substituted  in  the  adamantyl  ring  to  any  extent.
Substances specified under this subdivision include:

a.

1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-adaman-

toyl)indole, commonly known as AM-1248;

b.    1-pentyl-3-(1-adamantoyl)indole,  commonly  known  as

AB-001;

8.    Any  compound  structurally  derived  from  3-(cyclo-
propoyl)indole by substitution at the nitrogen atom of the indole
ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl,  1-(N-methyl-2-piperidinyl)methyl,  2-(4-mor-
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-
3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not further substituted in the indole ring to any extent,

amide, commonly known as STS-135;

10.  Any compound structurally derived from N-adamantyl-
1H-indazole-3-carboxamide  by  substitution  at  either  nitrogen
atom  of  the  indazole  ring  with  alkyl,  haloalkyl,  cyanoalkyl,
alkenyl,  cycloalkylmethyl,  cycloalkylethyl,  1-(N-methyl-2-
1-(N-methyl-2-
piperidinyl)methyl,
pyrrolidinyl)methyl,
or
(tetrahydropyran-4-yl)methyl group, whether or not further sub-
stituted in the indazole ring to any extent, whether or not substi-
tuted in the adamantyl ring to any extent.  Substances specified
under this subdivision include:

2-(4-morpholinyl)ethyl,
1-(N-methyl-3-morpholinyl)methyl,

a.    1-pentyl-N-(1-adamantyl)-1H-indazole-3-carboxamide,

commonly known as AKB48;

b.    1-(5-fluoropentyl)-N-(1-adamantyl)-1H-indazole-3-car-

boxamide, commonly known as 5F-AKB48.

11.    Any  compound  structurally  derived  from  N-naphthyl-
1H-indazole-3-carboxamide  by  substitution  at  either  nitrogen
atom  of  the  indazole  ring  with  alkyl,  haloalkyl,  cyanoalkyl,
alkenyl,  cycloalkylmethyl,  cycloalkylethyl,  1-(N-methyl-2-
piperidinyl)methyl,
1-(N-methyl-2-
or
pyrrolidinyl)methyl,
(tetrahydropyran-4-yl)methyl group, whether or not further sub-
stituted in the indazole ring to any extent, whether or not substi-
tuted in the naphthyl ring to any extent.

2-(4-morpholinyl)ethyl,
1-(N-methyl-3-morpholinyl)methyl,

12.    [1,1’-biphenyl]-3-yl-carbamic  acid,  cyclohexyl  ester,

commonly known as URB-602;

13.

[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-

phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenan-
thridin-1-yl] acetate, commonly known as CP 50,556-1;

14.

(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol,
commonly known as HU-210;

15.

(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol,
commonly known as HU-211;

16.    3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-
cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione,  com-
monly known as HU-331;

17.

((6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-

2023-24 Wisconsin Statutes updated through 2025 Wis. Act 247 and through all Supreme Court Orders and Controlled Sub-
stances Board Orders filed before and in effect on October 1, 2026.  Published and certified under s. 35.18.  Changes effective af-
ter October 1, 2026, are designated by NOTES. (Published 10-1-26)

Updated 2023-24 Wis. Stats.  Published and certified under s. 35.18.  October 1, 2026.

 961.14

UNIFORM CONTROLLED SUBSTANCES ACT

Updated 23-24 Wis. Stats.

  10

6a,7,10,10a-tetrahydrobenzo[c]chromen-9-yl)methanol,
monly known as JWH-051;

com-

18.    (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahy-
dro -6,6,9-trimethyl-6H-dibenzo[b,d]pyran, commonly known as
JWH-133;
19.

  (6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-[(2R)-1,1,2-
trimethylbutyl]-6a,7,10,10a-tetrahydrobenzo[c]chromene,  com-
monly known as JWH-359;

20.    Napthalen-1-yl-(4-pentyloxynapthalen-1-yl)methanone,

commonly known as CB-13;

21.    N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-unde-

camide, commonly known as CB-25;

22.

  N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-unde-

camide, commonly known as CB-52;

23.

  N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-
commonly

pentyloxy-1,2-dihydroquinoline-3-carboxamide,
known as JTE-907;

24.    N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-yli-
com-

dene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide,
monly known as A-836,339;

25.    Anthracen-9-yl{2-methyl-1-[2-(morpholin-4-yl)ethyl]-

1H-indol-3-yl}methanone, commonly known as WIN 56,098;

26.

  6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzox-

azin-4-one, commonly known as URB-754;

27.  [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate,

commonly known as URB-597;

28.  (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-

trifluorobutyl-1-sulfonate, commonly known as BAY 38-7271.

29.  Any compound structurally derived from 1H-indole-3-
carboxylic  acid  quinolinyl  ester  by  substitution  at  the  nitrogen
atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
1-(N-methyl-2-
cycloalkylmethyl,
cycloalkylethyl,
1-(N-methyl-2-
2-(4-morpholinyl)ethyl,
piperidinyl)methyl,
pyrrolidinyl)methyl,
or
1-(N-methyl-3-morpholinyl)methyl,
(tetrahydropyran-4-yl)methyl group, whether or not further sub-
stituted in the indole ring to any extent, whether or not substituted
in the quinoline ring to any extent.  Substances specified under
this subdivision include:

a.    1-pentyl-1H-indole-3-carboxylic  acid  8-quinolinyl  ester,

commonly known as PB-22;

b.    1-(5-fluoropentyl)-1H-indole-3-carboxylic  acid  8-quino-

linyl ester, commonly known as 5F-PB-22;

c.    1-(cyclohexylmethyl)-1H-indole-3-carboxylic  acid  8-

quinolinyl ester, commonly known as BB-22.

30.    Any  compound  structurally  derived  from  N-naphthyl-
1H-indole-3-carboxamide by substitution at the nitrogen atom of
the  indole  ring  with  alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cy-
1-(N-methyl-2-
cloalkylmethyl,
cycloalkylethyl,
piperidinyl)methyl,
1-(N-methyl-2-
or
pyrrolidinyl)methyl,
(tetrahydropyran-4-yl)methyl group, whether or not further sub-
stituted in the indole ring to any extent, whether or not substituted
in  the  naphthyl  ring  to  any  extent.    Substances  specified  under
this subdivision include:

2-(4-morpholinyl)ethyl,
1-(N-methyl-3-morpholinyl)methyl,

a.  1-pentyl-N-(1-naphthyl)-1H-indole-3-carboxamide, com-

monly known as NNEI or MN-24;

b.    1-(5-fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carbox-

amide, commonly known as 5F-NNEI or 5F-MN-24.

31.    Any  compound  structurally  derived  from  3-(pyridi-
noyl)indole by substitution at the nitrogen atom of the indole ring
by  alkyl,  haloalkyl,  cyanoalkyl,  alkenyl,  cycloalkylmethyl,  cy-
cloalkylethyl,
2-(4-mor-
pholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-

1-(N-methyl-2-piperidinyl)methyl,

3-morpholinyl)methyl,  or  (tetrahydropyran-4-yl)methyl  group,
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the pyridine ring to any extent.  Sub-
stances specified under this subdivision include:

a.  1-pentyl-3-(3-pyridinoyl)indole;
b.  1-(5-fluoropentyl)-3-(3-pyridinoyl)indole.
32.    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluoroben-
zyl)-1H-indazole-3-carboxamide,  commonly  known  as  AB-
FUBINACA.
32m.

  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-
1H-indazole-3-carboxamide,  commonly  known  as  ADB-
BUTINACA.
33.

  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-
1H-indazole-3-carboxamide,  commonly  known  as  ADB-
PINACA.

34.    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexyl-
methyl)-1H-indazole-3-carboxamide, commonly known as AB-
CHMINACA.

35.    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-in-

dazole-3-carboxamide, commonly known as AB-PINACA).

36.

[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-

yl)methanone, commonly known as THJ-2201.

37.

  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclo-
hexylmethyl)-1H-indazole-3-carboxamide, commonly known as
MAB-CHMINACA or ADB-CHMINACA.

38.  Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxam-

ido)-3,3-dimethylbutanoate, commonly known as 5F-ADB.

38m.  Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxam-
ido)-3,3-dimethylbutanoate,  commonly  known  as  4F-MDMB-
BINACA or 4F-MDMB-BUTINACA.

39.  Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxam-

ido)-3-methylbutanoate, commonly known as 5F-AMB.

40.

  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluo-
robenzyl)-1H-indazole-3-carboxamide,  commonly  known  as
ADB-FUBINACA.

41.  Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxam-
ido)-3,3-dimethylbutanoate  commonly  known  as  MDMB-
CHMICA.

42.  Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxam-
ido)-3,3-dimethylbutanoate,  commonly  known  as  MDMB-
FUBINACA.

43.  Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxam-
ido)-3-methylbutanoate,  commonly  known  as  FUB-AMB,
MMB-FUBINACA or AMB-FUBINACA.

43m.  Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxam-
ido)-3-methylbutanoate, commonly known as MMB-FUBICA or
AMB-FUBICA.

44.    Naphthalen-1-yl  1-(5-fluoropentyl)-1H-indole-3-car-

boxylate, commonly known as NM2201.

45.

  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluo-
ropentyl)-1H-indazole-3-carboxamide, commonly known as 5F-
AB-PINACA.

46.  1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-
4-CN-CUMYL-

commonly

known

as

3-carboxamide,
BUTINACA.

47.  Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxam-
ido)-3-methylbutanoate, commonly known as MMB-CHMICA.
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-
pyrrolo[2,3-b]pyridine-3-carboxamide, commonly known as 5F-
CUMYL-P7AICA.

48.

49.    Ethyl  2-(1-(5-fluoropentyl)-1H-indazole-3-carboxam-
ido)-3,3-dimethylbutanoate,  commonly  known  as  5F-EDMB-
PINACA.

2023-24 Wisconsin Statutes updated through 2025 Wis. Act 247 and through all Supreme Court Orders and Controlled Sub-
stances Board Orders filed before and in effect on October 1, 2026.  Published and certified under s. 35.18.  Changes effective af-
ter October 1, 2026, are designated by NOTES. (Published 10-1-26)

Updated 2023-24 Wis. Stats.  Published and certified under s. 35.18.  October 1, 2026.

11  Updated 23-24 Wis. Stats.

UNIFORM CONTROLLED SUBSTANCES ACT

961.14

50.  Methyl 2-(1-(5-fluoropentyl)-1-indole-3-carboxamido)-
3,3-dimethylbutanoate, commonly known as 5F-MDMB-PICA.
51.    N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide,  commonly  known  as  FUB-AKB48,  FUB-AP-
INACA or AKB48 N-(4-FLUOROBENZYL).

52.

  1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-inda-
zole-3-carboxamide, commonly known as 5F-CUMYL-PINACA
or SGT-25.

53.    (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethyl-

cyclopropyl)methanone, commonly known as FUB-144.

54.  Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-
3-carboxamido)butanoate,  commonly  known  as  MDMB-4en-
PINACA.

55.    Methyl  2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-
3,3-dimethyl-butanoate,  commonly  known  as  4F-MDMB-BU-
TICA or 4F-MDMB-BICA.

56.    N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-
en-1-yl)-1H-indazole-3-carboxaminde,  commonly  known  as
ADB-4en-PINACA.

57.    5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-
one, commonly known as CUMYL-PEGACLONE or SGT-151.
58.    Ethyl  2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-
3,3-dimethyl-butanoate,  commonly  known  as  5F-EDMB-PICA
or 5F-EDMB-2201.

(u)    1-[1-(2-thienyl)cyclohexyl]piperidine,  which  is  the  thio-

phene analog of phencyclidine;

(ud)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thio-

phene pyrrolidine analog of phencyclidine;

(ug)    N-ethyl-1-phenylcyclohexylamine,  which  is  the  ethy-

lamine analog of phencyclidine;

(ur)  1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrroli-

dine analog of phencyclidine;

(uv)

  2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone,

commonly known as methoxetamine.
(v)  2,5-dimethoxyamphetamine;
(w)  4-bromo-2,5-dimethoxyamphetamine, commonly known

as “DOB”;

(wa)    4-iodo-2,5-dimethoxyamphetamine,  commonly  known

as DOI.
(wb)

  4-chloro-2,5-dimethoxyamphetamine,  commonly

known as DOC.

(wg)    4-bromo-2,5-dimethoxy-beta-phenylethylamine,  com-

monly known as "2C-B" or "Nexus";

(wgm)    4-iodo-2,5-dimethoxy-beta-phenylethylamine,  com-

monly known as “2C-I”.

(wh)    2,5  dimethoxy-4-(n)-propylthiophenethylamine,  com-

monly known as “2C-T-7”;

(wi)  Alpha-methyltryptamine, commonly known as "AMT";
(wj)

  5-methoxy-N,  N-diisopropyltryptamine,  commonly

known as "5-MeO-DIPT";

(wq)

  2,5-dimethoxy-4-nitrophenethylamine,  commonly

known as 2C-N.

(wr)    2,5-dimethoxy-4-(n)-propylphenethylamine,  commonly

known as 2C-P.

(ws)    Any  compound  structurally  derived  from  N-benzyl-2-
(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen
atom,  or  on  either  ring,  with  alkyl,  alkoxy,  alkylenedioxy,
haloalkyl, hydroxyl, halide or nitro substituents, or by any combi-
nation  of  these  modifications.    Substances  specified  under  this
paragraph include:

1.

2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-
methoxyphenyl)methyl]ethanamine,  commonly  known  as  25I-
NBOMe.
2.

2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-
methoxyphenyl)methyl]ethanamine,  commonly  known  as  25C-
NBOMe.
3.

2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-
methoxyphenyl)methyl]ethanamine,  commonly  known  as  25B-
NBOMe.
4.

2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxyben-

zyl)ethanamine, commonly known as 25E-NBOMe.

(wv)  N,N-diallyl-5-methoxytryptamine, commonly known as

5-MeO-DALT.

(ww)  5-(2-aminopropyl)benzofuran, commonly known as 5-

APB.

(wx)  6-(2-aminopropyl)benzofuran, commonly known as 6-

APB.

(wy)    5-(2-aminopropyl)-2,3-dihydrobenzofuran,  commonly

known as 5-APDB.

(wz)    6-(2-aminopropyl)-2,3-dihydrobenzofuran,  commonly

known as 6-APDB.

(x)  4-methoxyamphetamine, commonly known as "PMA."
(xa)  5-iodo-2-aminoindane, commonly known as 5-IAI.
(xb)    4-methoxymethamphetamine,  commonly  known  as

PMMA.

(xc)  3-methoxyphencyclidine, commonly known as 3-MeO-

PCP.

Instrument

Controlled substance analog treated as a schedule I substance (deeming clause) and the controlled-substance-analog definition

Source

https://docs.legis.wisconsin.gov/statutes/statutes/961.pdf

Retrieved

2026-07-20

Fingerprint

0a7fd287ab38c917

961.25 Controlled substance analog treated as a schedule I substance. A controlled substance analog, to the extent it is intended for human consumption, shall be treated, for the purposes of this chapter, as a substance included in schedule I, unless a different treatment is specifically provided. No later than 60 days after the commencement of a prosecution concerning a controlled substance analog, the district attorney shall provide the controlled substances board with information relevant to emergency scheduling under s. 961.11 (4m). After a final determination by the controlled substances board that the controlled substance analog should not be scheduled, no prosecution relating to that substance as a controlled substance analog may be commenced or continued.
961.01 (4m) (a) “Controlled substance analog” means a substance the chemical structure of which is substantially similar to the chemical structure of a controlled substance included in schedule I or II and: 1. Which has a stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system of a controlled substance included in schedule I or II; or 2. With respect to a particular individual, which the individual represents or intends to have a stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system of a controlled substance included in schedule I or II.